LHN Ltd Shows Strong Co-Living Growth Despite Property Development Weakness, Maintains BUY Rating with S$0.77 Target Price June 4, 2026

LHN Ltd Shows Strong Co-Living Growth Despite Property Development Weakness, Maintains BUY Rating with S$0.77 Target Price

Company Overview

LHN Ltd operates a diversified business portfolio encompassing industrial facilities, facilities management, co-living operations through its Coliwoo brand, and property development. The company has positioned itself as a key player in Singapore’s co-living market whilst maintaining traditional property-related revenue streams.


Mixed Performance in 1H26 Results

LHN Ltd delivered 1H26 results that met expectations, with revenue and adjusted profit after tax and minority interests representing 43% and 49% of full-year forecasts respectively. However, overall revenue declined 14% due to the complete absence of property development revenue during the period. The company maintained its interim dividend at 1 cent, demonstrating its commitment to shareholder returns despite the revenue headwinds.


Strong Co-Living Portfolio Expansion

The standout performer was Coliwoo, LHN’s co-living franchise, which demonstrated impressive growth metrics. The portfolio expanded significantly, with room count increasing 38% year-on-year to 3,568 units. This growth was bolstered by the March opening of Coliwoo Midtown on Middle Road, which contributed 212 rooms and achieved 55% occupancy since launch. The co-living division generated revenue of S$26.9 million, representing a robust 17% year-on-year increase driven by the substantial expansion in room inventory.

Demand fundamentals remain exceptionally strong, with average occupancy across the portfolio maintained at an impressive 97% level. The pipeline remains healthy, with another 1,021 rooms scheduled for development, representing a 29% increase to the current portfolio size.


Key Positives and Negatives

The Positive: Strong growth momentum in the Coliwoo portfolio underpinned performance, with revenue climbing 17% year-on-year to S$26.9 million supported by the 38% jump in room keys. The second half of FY26 is expected to deliver stronger performance as Coliwoo Midtown continues to ramp up occupancy levels.

The Negative: Property development operations faced significant challenges, recording zero sales from the 55 Tuas South Avenue 1 project during 1H26. Whilst two units were sold in April, only 9 of the 49 launched units have been sold to date, with the company now considering rental options for the remaining properties.


Investment Outlook and Recommendation

Phillip Securities Research maintains its BUY recommendation whilst adjusting the target price to S$0.77 from the previous S$0.85, reflecting a decline in Coliwoo’s market capitalisation. The valuation methodology applies a 20% discount to mark-to-market valuation due to price volatility, with property development valued at book value and remaining business valued at 10 times price-to-earnings ratio. The company offers an attractive dividend yield of 6.5%, with future growth expected from expanding the co-living franchise into dormitories for the services industry.


Frequently Asked Questions

Q: What were LHN Ltd's key financial results for 1H26?

A: Revenue and adjusted PATMI were 43% and 49% of full-year forecasts respectively. Overall revenue declined 14% due to the absence of property development revenue, whilst the interim dividend remained unchanged at 1 cent.

Q: How did the Coliwoo co-living business perform?

A: Coliwoo showed strong growth, with room count increasing 38% year-on-year to 3,568 units and revenue rising 17% to S$26.9 million. Average occupancy remained high at 97%.

Q: What is the growth pipeline for Coliwoo?

A: There are 1,021 rooms in the development pipeline, representing a 29% increase to the current portfolio. Coliwoo Midtown opened in March with 212 rooms and has achieved 55% occupancy since launch.

Q: What challenges did the property development division face?

A: The property development segment recorded no sales from the 55 Tuas South Avenue 1 project in 1H26. Only 9 of the 49 launched units have been sold, with the company now considering rental options for the remaining properties.

Q: What is Phillip Securities Research's investment recommendation?

A: Phillip Securities Research maintains a BUY recommendation with a target price of S$0.77, down from the previous S$0.85, reflecting a decline in Coliwoo's market capitalisation.

Q: What is LHN's dividend yield?

A: The company offers an attractive dividend yield of 6.5% to shareholders.

Q: What are the future growth prospects for LHN?

A: The next evolution of the Coliwoo franchise includes expanding into dormitories for the services industry, whilst the co-living business model captures management fees, rental income, and capital gains from assets.

Q: Why was the target price reduced despite maintaining the BUY rating?

A: The target price was lowered due to a decline in Coliwoo's market capitalisation, with a 20% discount applied to mark-to-market valuation due to price volatility.

LHN Ltd Shows Strong Co-Living Growth Despite Property Development Weakness, Maintains BUY Rating with S$0.77 Target Price

 

This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.

 

Disclaimer

These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.

Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.

Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com